Biotechnology Company NEUROKIN Strengthens its Board of Directors and Scientific Committee

The neuroprotective drugs development company announces today the appointment of two former Vice Presidents of Sanofi - Aventis; Bernard Reculeau, and Jesús Benavides.

scientist studying neurons

Cardiac Arrest

picture neurons if dissociated Cardiac Arrest study300 000 cardiac arrests occur each year in the US. Among these, it is estimated that between 6-10% patients survive. Among survivors only 10% are able to come back to previous activities.


No treatment is available as neuroprotective agent for post-cardiac arrest patients but hypothermia.

 

Featured links

scientist studies neurons cardiac arrest